Interestingly, however, it is unclear if the sir1 phenotype could be fully restored by further inhibiting GCL activity and if the activation of glutathione synthesis in sir1 would exacerbate the growth phenotype
However, whether these benefits were due to sulfonylurea therapy versus an overall glucose-lowering effect could not be confirmed (4)
Pharmacokinetics: ADMET of saxagliptin Despite having a short half-life of 2.2-3.8 hours, saxagliptin is able to maintain 24-hour glycemic control with single daily dosage due to the drugs slow disassociation from the DPP-4 enzyme (Drugs.com)
Pentadeca Arginate is structurally derived from BPC-157, a 15-amino acid peptide known for its regenerative and cytoprotective effects
Biochem Biophys Res Commun (2007) 354(4):87984.10.1016/j.bbrc.2007.01.058 113 CreaR
Cardiovascular disease, pregnancy, stimulant abuse history, and certain medication interactions all rule it out